We are currently in later phase trials the effectiveness of this the efficacy of this dosing schedule 7-on/7-off. .. Novel Xeloda dose schedule May Offer well-tolerated alternative for the treatment of advanced breast cancerA novel biweekly dosing schedule of Xeloda enabled safe delivery of higher daily doses in treatment of advanced breast cancer, according to an experimental study in the 10th Published April 2008 issue of the Journal of Clinical Oncology. Data data showed that a seven-days-on/seven-days-off regimen, called dose dense , was generally up to 2000 mg twice daily well tolerated and provides a possible alternative to the standard Xeloda dosing of 14 days and seven days .
Breast cancer is the most common cancer among women, other than skin cancer. According to the American Cancer Society , about 182,460 women in the United States is found in invasive breast cancer in 2008 have. Breast cancer is the second leading cause of cancer death in women, after lung cancer – about 40,930 women die from the disease this year. Or metastatic breast cancer cancer that has spread from the breast to other parts of the body, has a particularly poor prognosis, with a five-year survival rate of 27 %. Currently there are two and a half million women with breast cancer in the United States.Half blood on the maternal half-siblings concentrated rather as paternal half – brothers and sisters, because these kids tended full-time living by their biological nut and which same environmental impacts from of time that they were born aged between two that age of two, the time where the start of autistic syndromes. Compared them autism of recurrence under a 619 mother half-siblings on the 4832 rate under full siblings..